MyoPax wins the Deep Tech Berlin Award 2026

We are thrilled to share that MyoPax has won the Deep Tech Berlin Award 2026 in the Bio- and Healthtech category!

Presented by the Berlin Senate Department for Economics, Energy, and Public Enterprises, this award recognizes Berlin-based companies turning cutting-edge research into real-world impact. Being recognised for our work on novel cell and gene therapies for muscle tissue regeneration is a tremendous validation of our mission: bringing promising new treatment options to patients with devastating muscle diseases.

A big thank you to our team, our partners, and the deep-tech community in Berlin. We are proud to be part of this vibrant ecosystem!